ABSTRACT
INTRODUCTION
T RAUMATIC BRAIN INJURY (TBI) remains the leading cause of long-term neurological disabilities, including cognitive, sensory, motor and emotional impairments among children and young adults. An estimated 6 million Americans are currently living with a disability as a result of TBI (Thurman et al., 1999) .
It has been suggested that stem cells hold great potential for the repair of the damaged nervous system. The therapeutic potential of stem cells has been examined in experimental brain injury using a variety of approaches (Longhi et al., 2005; Schouten et al., 2004) . Stem cell transplants included murine or rat cell lines (Philips et al., 2001; Riess et al., 2002; Tate et al., 2002) , human cell lines (e.g., NT2N neurons) (Longhi et al., 2004; Muir et al., 1999; Watson et al., 2003; Zhang et al., 2005) , bone marrow-derived cell lines (Mahmood et al., 2001) , or even minced fetal cortical grafts were applied (Sinson et al., 1996; Soares et al., 1991; Soares et al., 1995) . Further experiments demonstrated long term survival and functional recovery following transplantation of bone marrow stromal (BMS cells) into experimentally injured animal brains (Mahmood et al., 2006) .
We were able to show in our own studies that the implantation of the murine neuronal stem cell (NSC) clone C17.2 into mice brain following controlled cortical impact injury resulted in improved motor function but failed to improve cognitive function (Riess et al., 2002) . These results are in accordance with a subsequent study by Hoane et al. reporting that transplantation of pre-differentiated ES cells improved behavioural outcome on sensorimotor and locomotor tests but failed to improve cognitive function during memory tasks assessed by Morris water maze (Hoane et al., 2004 ). An improvement of motor function was also demonstrated when motoneuronenriched neural cells derived from mouse embryonic stem cells were transplanted after cryogenic brain injury (Chiba et al., 2003) .
TBI is associated with a massive loss of multiple cell types due to primary mechanical tissue disruption, bleeding, and secondary insults such as oedema and rise of intra-cranial pressure leading to cell necrosis. The choice of stem cell population utilized in replacement therapies after TBI might therefore be critical. Pluripotent murine embryonic stem cells (D3) have been shown to survive and differentiate into neuronal cell types following transplantation into rat brains in an experimental stroke model. Furthermore, enhanced green fluorescent protein (eGFP) transfected D3 cells have been shown to migrate along the corpus callosum to the ventricular walls and to populate the borderzone of the damaged brain tissue on the hemisphere opposite to implantation site, indicating that ES cells have high migrational dynamics (Erdo et al., 2003 (Erdo et al., , 2004 Hoehn et al., 2002) .
Based on these results, we have implanted undifferentiated eGFP-transfected, murine stem cells (D3) into the ipsilateral cortex of rat brains following the induction of a moderate/severe lateral fluid-percussion injury (Dixon et al., 1987; MCIntosh et al., 1989) .
Functional analyses were performed on: TBI animals with ES cells (n ϭ 7); TBI animals with PBS (control n ϭ 8) and sham animals (no injury, no transplantation [n ϭ 9]).
Differentiation and integration of embryonic stem cells was not observed at any time point. Long-term in vivo survival of stem cells (7 weeks) was negligible. Sporadic tumor formation was observed. However, transplantation of undifferentiated ES cells was demonstrated to significantly improve functional outcome on a range of behavioural tasks. A distinct improvement in motorfunctions was observed as early as one week following implantation of undifferentiated embryonic stem cells. Possible mechanisms underlying the improvement in functional outcome are discussed.
METHODS

Cell Culture and Preparation for Transplantation
The mouse D3 cell line, stable transfected with the pCX-(␤-act)-eGFP expression vector (Arnhold et al., 2000) , was maintained in Dulbecco's modified Eagle medium containing 15% fetal calf serum, non-essential amino acids, penicillin-streptomycin, 50 mol/L ␤-2 mercaptoethanol (Merck, Darmstadt, Germany), and 100 mmol/L leukemia-inhibiting factor (LIF) (ESGRO ® , Chemicon Int., Temecula, CA) (Williams et al., 1988) . The ES cells were provided by Professor Hescheler (Department of Anatomy, Medical School, Univeristy of Cologne, Germany).
For transplantation, the ES cells were trypsinized, gently triturated in serum-containing medium to inactivate the trypsin, and washed three times by gently pelleting the cells at low-speed centrifugation (900g). The cells were resuspended in phosphate-buffered saline (PBS) (pH 7.4; Biochrom AG, Berlin, Germany) to yield a final concentration of 1 ϫ 10 5 cells/L. Trypan blue was used to assess their viability. The suspension was kept on ice and gently triturated prior to each injection to keep the suspension dispersed and free of cell clumps.
Animal Preparation and Induction of the Injury
Adult, male Sprague-Dawley rats (Harlan-Winkelmann, Borchen, Germany, n ϭ 42, 276-350 g) were given access to food and water ad libitum.
STEM CELL TRANSPLANTATION AFTER TBI
All animal procedures conformed to the guidelines of the University of Cologne and the state's animal protection and ethics committee. All efforts were made to minimize animal discomfort and to reduce the total number of animals used.
Animals were anesthetized with sodium pentobarbital (60 mg/kg, intraperitones ) and then surgically prepared for lateral FP brain injury or sham operation as originally described (Mcintosh et al., 1989) . In brief, a 5-mm craniotomy was performed over the left parietal cortex, between lambda and bregma, leaving the dura mater intact. A hollow female Luer-Lok fitting was positioned over the craniotomy and held in place with dental cement. Animals were attached to the fluid percussion (FP) device (a saline-filled cylinder) via the female Luer-Lok. In a subset of animals (n ϭ 30) moderate/severe (2,4 atm) brain injury was then induced by a rapid injection of a pressure pulse of saline into the closed cranial cavity. Sham-operated animals (n ϭ 9) were anesthesized and surgically prepared as described, but were not subjected to brain injury. After brain injury or sham-operation, the Luer-Lok and the dental cement were removed, and the skin was sutured. Animals recovered after injury or shamoperation on heating pads to maintain normothermia.
Transplantation
Three days post-injury, animals were re-anesthetized via an injection of sodium pentobarbital (60 mg/kg, ip), and placed in a stereotaxic head holder. This transplantation protocol was based on previous work in experimental TBI models in which transplantation of cells (C17.2) showed extended graft survival, viability and improved neurological function (Philips et al., 2001; Riess et al., 2002) .
Thereafter, each animal received randomly one stereotactic injection underneath the injury cavity (AP ϭ Ϫ3.4, ML ϭ 5.0, DV ϭ Ϫ3.2 mm from bregma) of 1 L of cell suspension with 1 ϫ 10 5 ES cells/l or 1 L of PBS (control animals) using a 26-gauge Hamilton syringe. This transplant paradigm was based on previous work in experimental TBI models in which transplantation of postmitotic human neurons showed extended graft survival and viability Philips et al., 1999) .
To prevent graft-vs-host reactions 10 mg/kg CsA in saline vehicle ip (10 mg/mL, Sandimmune ® , Novartis, Basel) was injected before transplantation and daily thereafter for 2 weeks. All brain injured animals including animals receiving PBS buffer instead of ES cells and sham controls were treated with CsA.
TBI surviving animals (n ϭ 21), were randomized to receive either transplantation of murine embryonic stem cells (n ϭ 10) or control, PBS injection (n ϭ 11) animals.
Three animals died within the next 20 days of each transplantation group. Another group (n ϭ 9) underwent only the initial surgical procedure without any injury or injections into the brain and served as sham controls.
A subgroup of animals (n ϭ 4) received brain injury followed by ipsilateral ES cell transplantation of 5 L cell suspension 3 days post-trauma. These animals were used for histological analysis at one week post-transplantation and were not evaluated for behavior deficits.
Assessment of Neurologic Motor Function
Neurologic motor function was evaluated 24 h before injury, 72 h after injury, and 1, 3, and 6 weeks after transplantation. Evaluation of motor function was performed by blinded, trained observers using standard, well-established tests of balance, vestibulomotor function and coordination.
Composite Neuroscore
The composite neuroscore paradigm employed a previously described battery of behavioral tests (McIntosh et al., 1989) Performance in this battery of neurological tests has been shown to correlate with injury severity and to be sensitive to pharmacological interventions (Riess et al., 2001 ). Animals were graded using a scale from 4 (normal) to 0 (severely impaired) for each of the following seven indices: (1) left and (2) right forelimb contraflexion upon suspension by the tail, (3) left and (4) right hind limb flexion when the forelimbs remain on a surface and the hind limbs are lifted up and back by the tail, and (5) left and (6) right resistance to lateral pulsing; A composite neuroscore (maximum score ϭ 24) was generated by combining the scores for each of these tests.
Rotarod Test
The rotarod test is a reliable indicator of motor deficits after TBI. The rotarod device consists of a plexiglas frame with a 70-mm outer diameter motorized rotating rod. The rod started at an initial velocity of 5 rpm and accelerated at 5 rpm/10 sec. For acceleration, the latency from the start of the test until the rat fell completely off or gripped the device and spun around was recorded. All animals were acclimated to the rotarod before injury. Initial rotarod tests were performed 24 h before brain injury or sham-operation to record the baseline latencies for each animal. The sum of two trials was taken during baseline evaluation and post-injury testing.
Immunohistochemistry
In order to determine the survival, localization, extent of engraftment, and differentiation of ES cells in the trau-RIESS ET AL. matically injured brain, rats used for histological evaluation were sacrificed at one week, and all other animals, used for behavioral assessment were sacrificed at 7 weeks after transplantation by an overdose of sodium pentobarbital (200 mg/kg, i.p.). Subsequently, animals were transcardially perfused with 200 ml heparinized PBS (Biochrom) followed by 250 mL of 2% paraformaldehyde (Merck, Darmstadt, Germany) solution. Brains were removed from the skull, post-fixed in 2% paraformaldehyde for 2 days, processed and embedded in paraffin blocks.
Coronal sections (6 m) from bregma 1.0 to Ϫ5.0 mm were cut using a microtome and mounted on poly-L-lysine coated glass slides. Hematoxylin-eosin and Nissl staining were used to examine the gross anatomical changes.
Dewaxing and rehydration were done according to generic protocols using xylene and alcohol baths. Endogenous peroxidase and alkaline phosphatase were quenched using 1% H 2 O 2 (Merck) in Methanol (Merck) and 0.1 mol levamisole (Serva, Heidelberg, Germany) in distilled water, both for 20 min, respectively. The sections were boiled in buffered solution (2.1 g sodium citrate [Merck]/L distilled water, pH 6.0) in a microwave (1200 W, two times for 7 min). Non-specific binding was inhibited by treating the sections with 5% normal goat serum.
Brain sections were incubated with rabbit polyclonal anti-GFP antibody to detect the transplanted GFP expressing ES cells (Santa Cruz Biotechnologies, Santa Cruz, CA). Mouse monoclonal antiCD-68/ED-1 was applied to depict inflammatory responses, i.e. activation of microglial cells/macrophages (Serotec, Düsseldorf, Germany). Mouse monoclonal anti-nestin (Chemicon, Limburg, Germany) was applied to evaluate potential differentiation of transplanted ES cells into neural lineages (Cattaneo et al., 1990) , Anti-GFAP (glial fibrillary acidic protein, Sigma) was used to detect astrocytes. Brain sections were incubated for 24 h at 4°C overnight in PBS (pH 7.4) supplemented with 5% normal goat serum and 0.3% Triton X-100. The concentration of all primary antibodies was 1:100. Subsequently, sections were washed and incubated with biotinylated goat anti-mouse or anti-rabbit antibodies (1:150, DAKO Cytomation, Hamburg, Germany) for 2 h at room temperature. Specific secondary antibody binding was detected using either streptavidinhorseradish peroxidase/chromogen 3,3-diaminobenzidine (VECTASTAIN Elite ABC, Vector Laboratories, Burlingame, CA) or streptavidin-horseradish alkaline phosphatase/NBT/BCIP (DAKO) systems as recommended by the manufacturer.
Conventional double-labeling was accomplished as previously described (Beschorner et al., 2002; Engel et al., 2000) . Utilizing primary antibodies derived from different species (antiED-1 mouse monoclonal antibody, anti-GFP rabbit polyclonal), as well as different labelling systems (peroxidase/DAB, alkaline phosphatase/NBT-BCIP) provided an experimental set up that excluded any possible cross-reaction or false-positive result.
For fluorescent double-labelling goat anti-mouse-FITC (1:30, 2 h at room temperature; Santa Cruz Biotechnologies) and goat anti-rabbit Cy3 (1:75, 2 h at room temperature; Sigma) was used.
In order to assess the extend of background staining due to non-specific antibody binding, sections directly adjacent to evaluated section (neighboring as far as 6-24 m), were incubated overnight with 5% normal goat serum (Biochrom), 0.3% Triton X-100 (Serva) in PBS (Biochrom; pH 7.4), omitting the primary antibody. Fluorescent-labelled and double-labelled sections were viewed with a Leica RB/DM conventional/fluorescent microscope or with a Leica RG/BDM confocal laser scanning microscope, respectively. Images were captured with imaging software DISKUS (Königswinter, Germany).
Statistical Analysis
Rotarod and body weight data were analyzed for each time point separately by one-way analysis of variance (ANOVA) comparing the three groups: sham controls, ES cell transplanted animals, and PBS-injected animals. In case of significant differences, pair wise comparisons of the groups were performed using t-test. Composite Neuroscore data were analyzed similarly but with nonparametric statistics (i.e., Kruskal-Wallis instead of ANOVA, and U-test instead of t-test). A p-value of Ͻ0.05 was considered significant.
RESULTS
Mortality after Brain Injury and Transplantation
A group of n ϭ 29 animals received a brain injury of moderate/severe severity (exerted pressure ϭ 2.3 atm). Eight animals subjected to brain injury died within the first 2 h following brain injury. Undifferentiated murine embryonic stem cells were transplanted into 10 of the surviving animals. Eleven brain injured animals were subjected to PBS injection and served as a control group. Within the first 20 days following engraftment and PBS injection 3 animals died within each group.
Another group (n ϭ 9) underwent only the initial surgical procedure without any injury and served as sham controls. All surgical procedures were performed on spontaneously breathing animals.
STEM CELL TRANSPLANTATION AFTER TBI
Injury-Dependent Modulation of Bodyweight
Injured animals showed a slight, non significant, decrease in weight loss when brain injured animals were compared to sham-operated animals. There were no significant differences in bodyweight between injured ES cell-treated and injured PBS-treated animals (Fig. 1) .
Embryonic Stem Cell Associated Improvement in Motor Function
Composite neuroscore. At 72 h post-injury, all injured animals revealed a significant impairment in motor function (p Ͻ 0.001) as compared to sham-operated animals ( Fig. 2) . At 1 week after PBS injection, the impairment of motor function was not altered in the control group. However, a distinct improvement in motor function was observed within 1 week following transplantation of ES cells, indicating a rapid ES cell associated amendment. The trend continued through weeks 3 and 6 post-transplantation, when statistically significant (p Ͻ 0.05) improvement in the composite neuroscore of animals receiving ES cell as compared to animals receiving PBS injection were determined. At week 6, the motor function of animals receiving ES cells was comparable to sham-operated animals.
Rotarod test. Prior to injury or surgery, animals later assigned as sham-operated animals exhibited equivalent latencies compared to those animals, that later received brain injury (Fig. 3) . A significant impairment in sensorimotor coordination, halving the latency time, was observed 72 h past injury. Motor function seemed to slightly improve in sham controls during the first week postsurgery possibly due to a modest learning effect. Confirming the results obtained by the composite neuroscore, performance in the rotarod test significantly improved post-injury within 1 week following implantation of ES cells, indicating an overall improvement of motor function in ES cell treated animals. The latency remained significantly elevated 3 and 6 weeks post-implantation of ES cells (p Ͻ 0.05; Fig. 3) . A modulation of locomotive motor function was not detected when animals were treated with PBS post-injury.
Time-Dependent Stem Cell Survival and Integration
Prior to ES cell transplantation procedures, the concentration of viable stem cells was higher than 85% reviled by Trypan blue staining. Stem cell survival and integration was examined by immunohistological methods 5 days and 7 weeks following implantation. Well-defined cell clusters were detected 1 week post-implantation in the periinjured cortex and subcortical white matter when brain sections were labelled with anti-GFP-antibodies (Fig. 4A,B morphology and a size at 5-12 m. Positive-staining for GFP was not observed in the PBS treated groups. Seven weeks post-implantation a small number of stem cells were identified in the area of the former implantation site in only one animal (Fig. 4C) . Migration of the implanted cells was not observed. The round/oval morphology implies an undifferentiated state of the GFP-positive stem cells. This result was underlined by doublestaining of these brain sections with anti-nestin, and GFAP antibodies. Although stained cells were detected, co-localization of stem cells and neural precursor or astrocyte marker stained cells, respectively, was not detected (data not shown).
Double staining of GFP and ED68, an antigen expressed in activated macrophages, revealed stem cells to be engulfed by activated macrophages 5 days post-implantation (Fig. 5) .
A morphological classified non-invasive benign chondroma was detected near the brain surface above the implantation needle-track in one of the two animals that developed tumors (Fig. 6) . It was not possible to explicitly determine the origin of the tumor in any of the animals, since GFP staining of the tissue remained negative.
DISCUSSION
We were able to demonstrate that transplantation of undifferentiated, embryonic stem cells following experimental traumatic brain injury significantly attenuates the impairment of motor function observed following brain injury.
Performance on the rotarod test and sensorimotor scores improved significantly when brain injured animals received ES cells rather than PBS. This is in accordance with previous brain injury studies that also reported recovery of function following cell transplantation. Improved behavioural outcome on sensorimotor and locomotor tests in brain injured animals was demonstrated following transplantation of pre-differentiated ES cells, neuronal precursor cells (C17-2) or minced fetal cortical grafts (E16), respectively (Hoane et al., 2004; Riess et al., 2002; Sinson et al., 1996) . However, survival and differentiation of implanted cells or grafts was either not studied or only demonstrated in small numbers, indicating the improvement of the neurological status to be mediated by a small number of surviving and to some extend differentiated cells (Borlongan et al., 1997; Chen et al., 2001; Riess et al., 2002; Saporta et al., 1999; Veizovic et al., 2001) .
In accordance with these findings only a few GFP-positive ES cells were detected at 7 weeks post-implantation. At 5 days post-implantation, surviving undifferentiated embryonic stem cells were detected in large clusters at the implantation site, indicating a massive loss of cells during the observation time.
The lack of survival/integration of ES cells may be related to the severity of injury. Latest reports by Shindo et al. described the differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury in mice. Following mild TBI transplanted neurospheres could survive in the hippocampus (CA3), but barely survived following severe TBI. We applied an injury that was defined as a moderate injury. However, due to the relatively high number of animals that did not survive TBI, the induced injuries has to be redefined as moderate to severe. Hence, the lack of survival of ES cells 13 weeks after transplantation might also be explained by the severity of injury.
The first week following TBI a strong inflammatory response was detected. Inhibition of host versus graft reaction by CsA might prevent T-cell mediated reactions following transplantation. Whether or not CsA could also have protective effects during unspecific inflammatory responses such as macrophages mediated ES cell phagocytosis has yet to be determined. Modo et al. (2002) ical evaluation of the immune response revealed no significant difference between animals treated with or without CSA.
A distinct leap of improvement in loco-motor function and coordination of movement was observed within 7 days, when clusters of undifferentiated stem cells were still present at the site of injury. Hence, improvement of neurological function cannot be assigned to the functional integration of stem cells and subsequent replacement of damaged tissue. Furthermore a significant improvement of motor function as compared to PBS treated control groups was determined for the entire observation period, when simultaneously a substantial loss of stem cells was recorded. Analogous to these findings, an integration and differentiation of implanted stem cells was not detected in our studies even after 7 weeks.
The functional improvements observed must therefore be regulated by mechanisms that are closely associated with the transplantation of ES cells but are independent of stem cell integration and differentiation. Plausible mechanisms may include the production/secretion of trophic factors, produced by ES cells (Kerr et al., 2003; Wilkins et al., 2003) . Latest findings endorse these assumptions. Undifferentiated embryonic C3 stem cells (also employed in the transplantation experiments) were demonstrated to rapidly release high levels of BDNF when conditioned with brain extract derived from healthy (HBE) or brain injured animals (TBE) (Bentz et al., 2006) .
Neuroprotection and functional restoration has also been discussed to be mediated through activated inflammatory cells at the site of injury as reported in earlier studies using fetal transplantation as an experimental therapeutic strategy for TBI (Yoles et al., 2001) . Anti-CD68/ED-1 staining of brain sections 5 days post-implantation, revealed a large number of activated mikroglial/macrophages in the injured cortex, near corpus callosum and adjacent to the ipsilaterally implanted stem cell cluster in our study, indicating a strong inflammatory response (Fig. 5) .
There is compelling evidence to indicate that in the injured nervous system, as in other tissues, macrophages are needed at an early stage after injury in order for healing to take place. Interestingly, recent findings indicate that immune cells are able to produce a variety of neurotrophic factors which promote neuronal survival and may also mediate anti-inflammatory effects (Correale et al., 2004) .
Additionally, it was shown, that trauma spontaneously evokes a beneficial T cell-dependent immune response, which reduces neuronal loss resulting in locomotor recovery following spinal cord injury in rodents (Yoles et al., 2001 ).
Our results indicate that functional improvement observed within seven days of transplantation might be due to the neuroprotective effects of neurotrophic factors released by the implanted stem cells rather than integration of stem cells and replacement of lost tissues (Park et al., 2006) . Infiltration of inflammatory cells might also have contributed to the augmentation of neuronal function as described in previous studies (Correale et al., 2004) .
We believe that long term improvement is the result of a strong inductive effect mediated by neurotrophic factors during the first week rather then a continuous stem cell dependent amendment, since immunohistochemical analysis, indicates a perpetual phagocytosis of stem cells over a period of 7 weeks (personal communications, (Molcanyi et al., 2006) .
Despite the neurological improvement reported here, we would like to point out that transplantation of undifferentiated stem cells also raises serious safety concerns. Erdö et al. (2003) were able to show that xenotransplantation of undifferentiated murine ES cells resulted in intense migration, neuronal differentiation and support of potential curative effects following ischemia-damaged rat brain, with almost no tumor formation. On the other hand, it was reported that homologous transplantation of embryonic stem cells into mouse brain produced highly malignant teratocarcinomas at the site of implantation, indicating xenotransplantation to inhibit carcinoma development.
Our findings are not concordant with these results. After transplantation of murine ES cells into the traumatic injured rat brain tumorigenesis was detectable in 20% of the animals.
Taken together this data suggests that the restitution of neurological motor function and repair process after ES transplantation might be caused by multiple mechanisms. Beneficial effects have to be increased; morbid effects (tumorigenity) have to be diminished. The effects of neurotrophic factors expressed by transplanted ES cells seem to be crucial. Also important for the therapeutic effects of ES cells are the secondary effects as e.g. inflammatory responses caused by ES cell injection. Furthermore phagocytosis of the ES cells is important to prevent the host brain of tumor formation.
These findings provide evidence for the therapeutic potential of ES cell transplantation after TBI in rats, but also raise serious safety concerns for human trails.
